Dammit, I told you so. I straight up, right here, told you Helius was going to move.

And move it has, up almost every day in the time since, for a 48% jump since I wrote about it on October 6.

Why has it moved? Because the story is getting out, at last, about the electrical oral device that Navy Seal divers learned helps the brain pay attention to what’s going on around it, helping patients with mobility struggles to better rehab their movement, helping brain patients start learning again, and helping folks who just need to pay attention to their surroundings (such as Navy Seal divers swimming for miles in pitch black darkness) stay focused.

Helius had drifted for a long time, with a lot of people interested in the technology but not necessarily waiting for it to pan out. Rarely do you catch the right point to jump in on a spiking biotech, because the moves come out of nowhere. This is the rare one where we got it spot on.


— Chris Parry

FULL DISCLOSURE: I own Helius stock but have no commercial relationship with the company.

Written By:

Chris Parry

A multi-Webster Award winner for excellence in BC journalism, Parry is the founder and publisher of Equity.Guru, which he built with the specific plan to blend old school reporting with stock promotion, in a way that puts the emphasis on truth, high standards, and ethics. Parry is a veteran of TV, radio, and print, and consults with public companies to help them figure out their storylines, lay down achievable milestones, and improve their communication with shareholders, while also posting regular deep dive analysis of companies in the public spotlight.

More By This Author
Health Science
Medical Devices
Helius Medical Technologies
0 0 votes
Article Rating
Notify of
Inline Feedbacks
View all comments
Would love your thoughts, please comment.x